Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
32
self-reported 11–50 band
Founded
Not recorded
Registry matches
2
ABR
Office countries
1
1 address
Funding rounds
2
Post IPO equity · Nov 2013 · US$ 21.5M
Company type
Public Company
self-reported
Legal entities
1 brand → 2 possible registrationsMatched by name against ABR, so this is a candidate list, not a confirmed identity. Confidence and match method are shown against every row.
NEUREN PHARMACEUTICALS (AUSTRALIA) PTY LIMITED
ABN45122593462
NEUREN PHARMACEUTICALS LIMITED
ABN72111496130
Legal entities
Show as table · Neuren Pharmaceuticals Limited: 2 registry entities
| NEUREN PHARMACEUTICALS (AUSTRALIA) PTY LIMITED | ABN 45122593462 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | ABN 72111496130 |
| Confirmed matches | 0 of 2 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for six debilitating neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUCamberwell, VIC 3124Primary
Grid intelligence Members
Funding
Last round · 21 November 2013US$ 21.5MPost IPO equity
Rounds2
Round typePost IPO equity · secondary transaction
Amount (USD)21,500,000
Stage rank6
Investors named0
Since last round12 yr 1 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 2014 to 2026 |
| Post IPO equity · 21 Nov 2013 | US$ 21.5M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entities operate under Neuren Pharmaceuticals Limited?
Two Australian entities on the ABR: NEUREN PHARMACEUTICALS (AUSTRALIA) PTY LIMITED (ABN 45 122 593 462) and NEUREN PHARMACEUTICALS LIMITED (ABN 72 111 496 130). Both medium confidence.
How many people work at Neuren Pharmaceuticals Limited?
32 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Neuren Pharmaceuticals Limited have offices?
One address on record, Australia only. Primary: Camberwell, VIC 3124.
Has Neuren Pharmaceuticals Limited raised funding?
Two rounds. Latest 21 November 2013: post IPO equity, US$21,500,000.
Which companies are listed alongside Neuren Pharmaceuticals Limited?
16 profiles list Neuren Pharmaceuticals Limited as a peer — 90th percentile in Biotechnology Research. It lists ten peers of its own. Recce Pharmaceuticals Ltd and CLINUVEL PHARMACEUTICALS LTD list it back.